DGAP-Adhoc: MOLOGEN AG: Early departure of CEO

Publication of an insider information pursuant to Section 17 of the regulation (EU) No. 596/2014

MOLOGEN AG: Early departure of CEO

Berlin, 17 March 2019 - MOLOGEN AG (ISIN DE000A2LQ900, SIN A2L Q90) (the "Company") announces that the Chief Executive Officer (CEO) of the Company, Dr Ignacio Faus, will depart from his post as Chairman and member of the Executive Board early, with effect from 31 March 2019 by mutual agreement with the Supervisory Board. Until he leaves the Company, Dr Faus will continue to be responsible for the Company's business.

The Supervisory Board of the Company will decide on the successor shortly.

Contact
Claudia Nickolaus
Head of Investor Relations & Corporate Communications
Tel: +49 - 30 - 84 17 88 - 38
Fax: +49 - 30 - 84 17 88 - 50
investor@mologen.com

Note about risk for future predictions
Certain information in this report contains forward-looking statements or the corresponding statements with negation or versions deviating from this or comparable terminology. These are described as forward-looking statements. In addition, all of the information given here that refers to planned or future results of business areas, key financial figures, developments of the financial situation or other financial figures or statistical data, is to be understood as such forward-looking statements. The company points out to investors that they should not rely on these forward-looking statements as predictions about actual future events. The company is not obligated and refuses to accept any liability for the forward-looking statements and has no obligation to update such statements in order to accurately reflect the current situation.